SCHEMBL15722801

SCHEMBL15722801

CCCCCCCCCCCn1cnc(Cl)c1Cl

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.47
NPSR1 Q6W5P4 1/20 0.46
TLR8 Q9NR97 3/20 0.43
ALDH1A1 P00352 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
KMT2A Q03164 2/20 0.40
LMNA P02545 1/20 0.40
PKM P14618 1/20 0.40
AMPD1 P23109 2/20 0.40
AMPD2 Q01433 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
POLB P06746 2/20 0.38
ADORA2A P29274 1/20 0.38
TBXAS1 P24557 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15722729 1.00 MAPT (0.47) MAPTNPSR1TLR8ALDH1A1TDP1
SCHEMBL15722749 1.00 MAPT (0.47) MAPTNPSR1TLR8ALDH1A1TDP1
SCHEMBL15722788 1.00 MAPT (0.47) MAPTNPSR1TLR8ALDH1A1TDP1
SCHEMBL15722731 1.00 MAPT (0.47) MAPTNPSR1TLR8ALDH1A1TDP1
SCHEMBL15722787 1.00 MAPT (0.47) MAPTNPSR1TLR8ALDH1A1TDP1
SCHEMBL13227914 1.00 MAPT (0.47) MAPTNPSR1TLR8ALDH1A1TDP1
SCHEMBL15722750 0.98 MAPT (0.49) MAPTNPSR1TLR8ALDH1A1TDP1
SCHEMBL5929136 0.92 MAPT (0.50) MAPTNPSR1TLR8ALDH1A1KMT2A
SCHEMBL15722722 0.84 MAPT (0.53) MAPTNPSR1ALDH1A1PKMSMN1; SMN2
SCHEMBL10915311 0.84 ALDH1A1 (0.46) TLR8ALDH1A1TDP1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278951-B2 Azolium and purinium salt anticancer and antimicrobial agents THE UNIVERSITY OF AKRON (US) 2016-03-08 US disclosed
US-9278951-B2 Azolium and purinium salt anticancer and antimicrobial agents THE UNIVERSITY OF AKRON (US) 2016-03-08 US disclosed
US-20140142307-A1 AZOLIUM AND PURINIUM SALT ANTICANCER AND ANTIMICROBIAL AGENTS THE UNIVERSITY OF AKRON 2014-05-22 US disclosed
US-20140142307-A1 AZOLIUM AND PURINIUM SALT ANTICANCER AND ANTIMICROBIAL AGENTS THE UNIVERSITY OF AKRON 2014-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140142307-A1 AZOLIUM AND PURINIUM SALT ANTICANCER AND ANTIMICROBIAL AGENTS PCNA, ITPA, MPI MAPT 3727/4885NPSR1 1332/4885TLR8 2985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.